Abstract
Background: Pain in oncology patients may be related to underlying disease process, as well as a side effect of chemotherapy and radiation. More than half of all patients with a diagnosis of cancer experience pain, which is often poorly controlled. As such, the treatment of pain in oncology patients demonstrates a significant need to develop new treatment options.
Objective: This review summarizes 35 patents on the treatment of pain among cancer patients. Method: A thorough literature review of all patents filed in 2014 was conducted using PubMed and http://ep.espacenet.com/ as sources identify new treatment options for cancer pain. Results: Our literature search returned 35 patents filed in 2014 related to the treatment of pain in cancer patients. Conclusion: In 2014, a number of patents were filed for the treatment of pain among oncology patients. The great variety of chemical compounds presented indicates that there is a great variety in current research for cancer-related pain. The development of novel treatment options will hopefully lead to more effective therapies in the treatment of cancer-related pain.Keywords: Cancer pain, chronic pain, oncology, oncologic pain, pain management, pain treatment.
Recent Patents on Anti-Cancer Drug Discovery
Title:Emerging Drugs for the Treatment of Cancer Pain: A Review of Patent Literature in 2014
Volume: 12 Issue: 2
Author(s): Brooke Anderson, Samuel Lee and Alaa Abd-Elsayed*
Affiliation:
- Department of Anesthesiology, University of Wisconsin School of Medicine and Public Health, Department of Anesthesiology, 600 Highland Avenue, B6/319 CSC, Madison, WI 53792-3272,United States
Keywords: Cancer pain, chronic pain, oncology, oncologic pain, pain management, pain treatment.
Abstract: Background: Pain in oncology patients may be related to underlying disease process, as well as a side effect of chemotherapy and radiation. More than half of all patients with a diagnosis of cancer experience pain, which is often poorly controlled. As such, the treatment of pain in oncology patients demonstrates a significant need to develop new treatment options.
Objective: This review summarizes 35 patents on the treatment of pain among cancer patients. Method: A thorough literature review of all patents filed in 2014 was conducted using PubMed and http://ep.espacenet.com/ as sources identify new treatment options for cancer pain. Results: Our literature search returned 35 patents filed in 2014 related to the treatment of pain in cancer patients. Conclusion: In 2014, a number of patents were filed for the treatment of pain among oncology patients. The great variety of chemical compounds presented indicates that there is a great variety in current research for cancer-related pain. The development of novel treatment options will hopefully lead to more effective therapies in the treatment of cancer-related pain.Export Options
About this article
Cite this article as:
Anderson Brooke, Lee Samuel and Abd-Elsayed Alaa *, Emerging Drugs for the Treatment of Cancer Pain: A Review of Patent Literature in 2014, Recent Patents on Anti-Cancer Drug Discovery 2017; 12 (2) . https://dx.doi.org/10.2174/1574892812666170406122121
DOI https://dx.doi.org/10.2174/1574892812666170406122121 |
Print ISSN 1574-8928 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3970 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Cancer Stem Cells: How can we Target them?
Current Medicinal Chemistry From TGF-β to Cancer Therapy
Current Drug Targets The Potential Use of Anticancer Peptides (ACPs) in the Treatment of Hepatocellular Carcinoma
Current Cancer Drug Targets Proteomics in Acute Myelogenous Leukaemia (AML): Methodological Strategies and Identification of Protein Targets for Novel Antileukaemic Therapy
Current Drug Targets Patents in Cancer Stem Cells
Recent Patents on Biomarkers The Expression Patterns and Clinical Significance of microRNAs in Liver Diseases and Hepatocellular Carcinoma
Current Pharmaceutical Design Synthesis and Biological Evaluation of 1, 3-Dihydroxyxanthone Mannich Base Derivatives as Potential Antitumor Agents
Letters in Drug Design & Discovery New Tubulin Polymerization Inhibitor Derived from Thalidomide: Implications for Anti-Myeloma Therapy
Current Medicinal Chemistry Aminopeptidases of Malaria Parasites: New Targets for Chemotherapy
Infectious Disorders - Drug Targets Turning Tumor-Promoting Copper into an Anti-Cancer Weapon via High-Throughput Chemistry
Current Medicinal Chemistry Safety Profile of Plasmid/Liposomes and Virus Vectors in Clinical Gene Therapy
Current Drug Safety Nanoparticle Delivery Systems for DNA/RNA and their Potential Applications in Nanomedicine
Current Topics in Medicinal Chemistry To Analyze the Amelioration of Phenobarbital Induced Oxidative Stress by Erucin, as Indicated by Biochemical and Histological Alterations
Anti-Cancer Agents in Medicinal Chemistry Plumbagin Inhibits Breast Tumor Bone Metastasis and Osteolysis by Modulating the Tumor-Bone Microenvironment
Current Molecular Medicine Interferon-α Treatment in Systemic Mastocytosis
Current Drug Targets Multidrug Resistance Through the Spectacle of P-Glycoprotein
Current Cancer Drug Targets Patent Selections
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery IL-17 Axis Driven Inflammation in Non-Alcoholic Fatty Liver Disease Progression
Current Drug Targets Peptide Activators of the p53 Tumor Suppressor
Current Pharmaceutical Design The Role of microRNAs in the Pathogenesis and Treatment of Hematopoietic Malignancies
Current Pharmaceutical Design